1. Home
  2. CPSS vs IPHA Comparison

CPSS vs IPHA Comparison

Compare CPSS & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

N/A

Current Price

$8.33

Market Cap

189.3M

Sector

Finance

ML Signal

N/A

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.71

Market Cap

169.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSS
IPHA
Founded
1991
1999
Country
US
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.3M
169.6M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
CPSS
IPHA
Price
$8.33
$1.71
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.00
AVG Volume (30 Days)
14.3K
19.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.59
N/A
Revenue
$393,506,000.00
N/A
Revenue This Year
$139.62
$22.29
Revenue Next Year
$10.58
$43.90
P/E Ratio
$14.13
N/A
Revenue Growth
11.79
N/A
52 Week Low
$6.67
$1.63
52 Week High
$11.42
$2.63

Technical Indicators

Market Signals
Indicator
CPSS
IPHA
Relative Strength Index (RSI) 42.56 44.33
Support Level $8.27 $1.68
Resistance Level $9.20 $1.86
Average True Range (ATR) 0.26 0.09
MACD -0.02 -0.01
Stochastic Oscillator 6.89 17.39

Price Performance

Historical Comparison
CPSS
IPHA

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: